Table 2: Showing variability of sensitivity depending on site of sample collection in 205 COVID-19 Wuhan patients [44].
Sample's source |
Sensitivity |
Bronchoalveolar lavage fluid specimens |
93% (14/15) |
Sputum |
72% (75/104) |
Nasal swabs |
63% (5/8) |
Fibro bronchoscope brush biopsy |
46% (6/13) |
Pharyngeal swabs |
32% (126/398) |
Feces |
29% (44/153) |
Blood |
1% (3/307) |